5cmn: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
==FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain==
==FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain==
<StructureSection load='5cmn' size='340' side='right' caption='[[5cmn]], [[Resolution|resolution]] 3.60&Aring;' scene=''>
<StructureSection load='5cmn' size='340' side='right'caption='[[5cmn]], [[Resolution|resolution]] 3.60&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5cmn]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CMN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5CMN FirstGlance]. <br>
<table><tr><td colspan='2'>[[5cmn]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5CMN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5CMN FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.605&#8491;</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5cmp|5cmp]]</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5cmn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5cmn OCA], [http://pdbe.org/5cmn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5cmn RCSB], [http://www.ebi.ac.uk/pdbsum/5cmn PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5cmn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5cmn OCA], [https://pdbe.org/5cmn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5cmn RCSB], [https://www.ebi.ac.uk/pdbsum/5cmn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5cmn ProSAT]</span></td></tr>
</table>
</table>
== Disease ==
== Disease ==
[[http://www.uniprot.org/uniprot/FLRT3_HUMAN FLRT3_HUMAN]] Kallmann syndrome. The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in FLRT3 also have a mutation in another HH-associated gene including FGFR1, HS6ST1 and FGF17 (PubMed:23643382).<ref>PMID:23643382</ref>
[https://www.uniprot.org/uniprot/FLRT3_HUMAN FLRT3_HUMAN] Kallmann syndrome. The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in FLRT3 also have a mutation in another HH-associated gene including FGFR1, HS6ST1 and FGF17 (PubMed:23643382).<ref>PMID:23643382</ref>  
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/FLRT3_HUMAN FLRT3_HUMAN]] May have a function in cell adhesion and/or receptor signaling. [[http://www.uniprot.org/uniprot/LPHN3_HUMAN LPHN3_HUMAN]] May be involved in the development of glutamatergic synapses in the cortex. Important in determining the connectivity rates between the principal neurons in the cortex (By similarity).  
[https://www.uniprot.org/uniprot/FLRT3_HUMAN FLRT3_HUMAN] May have a function in cell adhesion and/or receptor signaling.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 20: Line 21:
</div>
</div>
<div class="pdbe-citations 5cmn" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 5cmn" style="background-color:#fffaf0;"></div>
==See Also==
*[[Latrophilin|Latrophilin]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Arac, D]]
[[Category: Homo sapiens]]
[[Category: Lu, Y]]
[[Category: Large Structures]]
[[Category: Salzman, G]]
[[Category: Arac D]]
[[Category: Adgrl3]]
[[Category: Lu Y]]
[[Category: Cell adhesion-carbohydrate binding complex]]
[[Category: Salzman G]]
[[Category: Lrr repeat]]

Latest revision as of 08:39, 27 September 2023

FLRT3 LRR domain in complex with LPHN3 Olfactomedin domain

5cmn, resolution 3.60Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA